Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-Experienced Genotype 1 Hepatitis C Infected Patients (STARTverso 3)
Clinical trial NCT01358864 · COMPLETED
Trial details
- NCT number
- NCT01358864
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2013-02-01
- Enrollment
- 678
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.